Literature DB >> 8683527

Severe small airways disease resistant to medical treatment in a child with cystic fibrosis.

J Davies1, M Rosenthal, A Bush.   

Abstract

At the age of 12, a child with cystic fibrosis developed severe small airways obstruction of unknown aetiology, in the absence of significant bronchiectasis. He remained resistant to medical treatment until, following an exacerbation of allergic bronchopulmonary aspergillosis 18 months later, he responded to high dose oral steroids. He now remains steroid-dependent, and suffering from multiple side-effects. Possible aetiology and further therapeutic strategies are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8683527      PMCID: PMC1295708     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  6 in total

1.  An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma.

Authors:  B D Mazer; E W Gelfand
Journal:  J Allergy Clin Immunol       Date:  1991-05       Impact factor: 10.793

2.  Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.

Authors:  G B Winnie; R G Cowan; N A Wade
Journal:  J Pediatr       Date:  1989-02       Impact factor: 4.406

3.  Methotrexate in the treatment of steroid-dependent asthma.

Authors:  P D Dyer; T R Vaughan; R W Weber
Journal:  J Allergy Clin Immunol       Date:  1991-08       Impact factor: 10.793

4.  Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.

Authors:  D W Denning; J E Van Wye; N J Lewiston; D A Stevens
Journal:  Chest       Date:  1991-09       Impact factor: 9.410

5.  Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  J L Marchant; J O Warner; A Bush
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

6.  Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.

Authors:  A G Alexander; N C Barnes; A B Kay
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

  6 in total
  2 in total

Review 1.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance.

Authors:  Federico Cresta; Aldo Naselli; Federica Favilli; Rosaria Casciaro
Journal:  BMJ Case Rep       Date:  2013-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.